Mehmet Sönmez

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Crimean-Congo Hemorrhagic Fever in Turkey

S. Sami Kartı, Zekaver Odabaşı, Volkan Korten et al. · Emerging infectious diseases · 2004 · 307 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

The role of organic/bio–fertilizer amendment on aggregate stability and organic carbon content in different aggregate scales

Erdem Yılmaz, Mehmet Sönmez · Soil and Tillage Research · 2017 · 168 citations

Agriculture, Agronomy, Soil Sciences +17

Role of platelets in immune system and inflammation

Özge Sönmez, Mehmet Sönmez · Porto Biomedical Journal · 2017 · 159 citations · Full text

Veterinary Medicine, Hematology, Immunology +15